| Price | $21.88 |
| Year Range | $21.82 – $48.18 |
| Market Cap | $712M |
| PE Ratio | 17.22 |
| Industry | Drug Manufacturers |
What Is Collegium Pharmaceutical’s AI Stock Analysis?
Collegium Pharmaceutical’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Collegium Pharmaceutical’s momentum in near-real time.
Collegium Pharmaceutical (COLL) has an AltIndex AI Score of 56/100, currently a Hold signal. The AI Score distills Collegium Pharmaceutical's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Collegium Pharmaceutical’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Collegium Pharmaceutical — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving COLL’s AI Score?
Fundamentals
Revenue for the last quarter was $200M. This is an increase of 3.29% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 6.32%, suggesting positive year-over-year growth. Net income for the last quarter was $-15M. This represents a decrease of 203.83% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 225.60%, which may be a cause for concern. Ebitda for the last quarter was $71M. This represents a decrease of 21.85% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 24.81%, which may be a cause for concern. The current P/E ratio is 17.22. This appears to be within a normal range, neither particularly high nor low.
See Collegium Pharmaceutical’s earnings and insider transactions.
Technicals
Today's stock price is $21.88. This represents a decrease of 7.01% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 33.96%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $22.02, which is lower than the previous SMA10 of $22.09. This suggests a potential downward trend in price movement. The RSI is 76.2, indicating a potentially overbought (bearish) condition.
See the full technical analysis and price prediction.
Frequently Asked Questions: Collegium Pharmaceutical AI Stock Analysis
Collegium Pharmaceutical's AltIndex AI Score is 56/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Collegium Pharmaceutical a Hold (56/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Collegium Pharmaceutical — company overview, fundamentals, technicals and alternative data, with a recommendation. See the COLL AI Score or sign up to read the full thesis.
